Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies
RSC Medicinal Chemistry · 2026 · 17 (5) · 2549-2565
DOI: 10.1039/d6md00019c ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Dong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical Uni…. Die Arbeit nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Structure-based rational design yielded novel potent BCAT2 inhibitors C10 (IC 50 = 44 nM) and C11 (IC 50 = 54 nM), which exhibit 8–10-fold selectivity over BCAT1 and form stable, key interactions within the BCAT2 active pocket.
Autor:innen und Institutionen
- Key Laboratory of Structure-Based Drug Design & Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University Shenyang 110016 China spucgl@163.com.
- National Engineering Research Center for the Emergency Prevention and Control Drugs Beijing 100039 China shandongguojialin@163.com.
- Academy of Military Medical Sciences Beijing 100850 China.
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Zhongshan 528400 China hxie@simm.ac.cn.
- Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai 201203 China.
ORCID-Profile: Dong Xu, Guoliang Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Xu, D., Weng, W., Cao, H., Zhang, C., Zhang, Y., Li, Y., Xiao, J., Xie, H., Guo, J., & Chen, G. (2026). Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies. RSC Medicinal Chemistry, 17(5), 2549-2565. https://doi.org/10.1039/d6md00019c
Vancouver
Xu D, Weng W, Cao H, Zhang C, Zhang Y, Li Y, et al. Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies. RSC Medicinal Chemistry. 2026;17(5):2549-2565. doi:10.1039/d6md00019c
BibTeX
@article{Xu2026,
author = {Xu, Dong and Weng, Wenxiu and Cao, Huining and Zhang, Chao and Zhang, Yudi and Li, Yan and Xiao, Junhai and Xie, Hua and Guo, Jialin and Chen, Guoliang},
title = {Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studies},
journal = {RSC Medicinal Chemistry},
year = {2026},
volume = {17},
number = {5},
pages = {2549--2565},
doi = {10.1039/d6md00019c}
}
EUVIMED